Ticker Short Interest

JANX Short Interest Intelligence

Janux Therapeutics Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

JANX is classified as Neutral. Latest reported short interest is 7.1M shares; short interest changed -6.7%, price moved +10.2% since the previous report, short interest is in the 14th percentile, and days to cover is in the 14th percentile. Trend context is constructive.

Setup Score35/100Neutral
Reported Short Interest7.1M-6.7% vs prior report
Days To Cover3.5914.29 percentile
Price Reaction+10.2%since previous short report
Squeeze Pressure35crowding, trend, and pressure
Bearish Conviction6shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

35

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

6

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

14

Latest short interest is 7.1M shares and days to cover is 3.59.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

JANX Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 7108085 7615380 -6.7% 3.59 1978810
15 Jun 2026 7615380 8091847 -5.9% 10.96 694792
29 May 2026 8091847 7827096 3.4% 6.83 1184704
15 May 2026 7827096 7932981 -1.3% 9.66 810461
30 Apr 2026 7932981 7440069 6.6% 7.40 1072535
15 Apr 2026 7440069 7744629 -3.9% 8.27 900076
31 Mar 2026 7744629 10020131 -22.7% 5.51 1405554

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.